WASHINGTON – The U.S. Food and Drug Administration has approved the Pfizer COVID-19 Vaccine for use in children.
The agency announced the expanded emergency use authorization for the Pfizer-BioNTech COVID-19 Vaccine on Tuesday evening.
The two-dose vaccine can now be administered to adolescents 12 to 15 years of age.
Acting FDA Commissioner Janet Woodcock, M.D., made the following statement on the expansion:
“The FDA’s expansion of the emergency use authorization for the Pfizer-BioNTech COVID-19 Vaccine to include adolescents 12 through 15 years of age is a significant step in the fight against the COVID-19 pandemic,” said Dr. Woodcock. “Today’s action allows for a younger population to be protected from COVID-19, bringing us closer to returning to a sense of normalcy and to ending the pandemic. Parents and guardians can rest assured that the agency undertook a rigorous and thorough review of all available data, as we have with all of our COVID-19 vaccine emergency use authorizations.”
Pfizer was the first vaccine approved in the fight against the COVID-19 pandemic, back in December of 2020.